Alliance Pharma picks up three AstraZeneca antimalarial brands
Alliance Pharma (LON:APH) has acquired three anti-malarial brands from AstraZeneca (LON:AZN) for £4.2 million. Wholly-owned subsidiary Alliance Pharmaceuticals will sell Paludrine, Avloclor and Savarine mainly in the UK and France. ..
Original Article: Alliance Pharma picks up three AstraZeneca antimalarial brandsNEXT ARTICLE